{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:37:17Z","timestamp":1794591437188,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"crossref","award":["TMU108-AE1-B23"],"award-info":[{"award-number":["TMU108-AE1-B23"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The outcome of acute kidney injury (AKI) as a result of aminoglycosides (AGs) use remains uncertain in patients without prior chronic kidney disease (CKD). Therefore, we explored the outcomes of AGs use on AKI episodes associated with renal recovery and progress in patients without prior CKD in Taiwan. This was a retrospective cohort study by using the Taipei Medical University Research Database from January 2008 to December 2019. 43,259 individuals without CKD who had received parenteral AGs were enrolled. The exposed and unexposed groups underwent propensity score matching for age, gender, patients in intensive care unit\/emergency admission, and covariates, except serum hemoglobin and albumin levels. We identified an exposed group of 40,547 patients who used AGs (median age, 54.4\u00a0years; 44.3% male) and an unexposed group of 40,547 patients without AG use (median age, 55.7\u00a0years; 45.5% male). There was the risk for AKI stage 1 (adjusted hazard ratio [HR] 1.34; 95% confidence interval [CI] 1.00\u20131.79; <jats:italic>p<\/jats:italic>\u2009=\u20090.05) in patients that used AGs in comparison with the control subjects. Moreover, patients using AGs were significantly associated neither with the progression to acute kidney disease (AKD) stages nor with the progression to end-stage renal disease (ESRD) on dialysis. Further analyzed, there was an increased risk of AKI episodes for serum albumin levels less than 3.0\u00a0g\/dL and hemoglobin levels less than 11.6\u00a0g\/dL. Among patients without prior CKD, AGs-used individuals were associated with AKI risks, especially those at relatively low albumin (&lt;\u20093.0\u00a0g\/dL) or low hemoglobin (&lt;\u200911.6\u00a0g\/dL). That could raise awareness of AGs prescription in those patients in clinical practice.<\/jats:p>","DOI":"10.1038\/s41598-022-21074-x","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T10:03:04Z","timestamp":1665741784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Chu-Lin","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Chen","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Wen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Te","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Ho","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"21074_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.idc.2009.06.004","volume":"23","author":"LF Chen","year":"2009","unstructured":"Chen, L. F. & Kaye, D. Current use for old antibacterial agents: Polymyxins, rifamycins, and aminoglycosides. Infect. Dis. Clin. N. Am. 23, 1053\u20131075 (2009).","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"21074_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1086\/665724","volume":"33","author":"M Ababneh","year":"2012","unstructured":"Ababneh, M., Harpe, S., Oinonen, M. & Polk, R. E. Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: Implications for antimicrobial stewardship. Infect. Control Hosp. Epidemiol. 33, 594\u2013601 (2012).","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"Suppl 3","key":"21074_CR3","doi-asserted-by":"publisher","first-page":"S229","DOI":"10.1007\/BF01709706","volume":"16","author":"IA Bakker-Woudenberg","year":"1990","unstructured":"Bakker-Woudenberg, I. A. & Roosendaal, R. Impact of dosage schedule of antibiotics on the treatment of serious infections. Intensive Care Med. 16(Suppl 3), S229-234 (1990).","journal-title":"Intensive Care Med."},{"key":"21074_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1021\/cb3005116","volume":"8","author":"B Becker","year":"2013","unstructured":"Becker, B. & Cooper, M. A. Aminoglycoside antibiotics in the 21st century. ACS Chem. Biol. 8, 105\u2013115 (2013).","journal-title":"ACS Chem. Biol."},{"key":"21074_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1525-1497.1998.00224.x","volume":"13","author":"DL Paterson","year":"1998","unstructured":"Paterson, D. L., Robson, J. M. & Wagener, M. M. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J. Gen. Intern. Med. 13, 735\u2013739 (1998).","journal-title":"J. Gen. Intern. Med."},{"key":"21074_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz106.FP250","author":"L Valino-Rivas","year":"2019","unstructured":"Valino-Rivas, L. et al. Loss of NLRP6 expression increases the severity of acute kidney injury. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfz106.FP250 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"21074_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez-Novoa","year":"2011","unstructured":"Lopez-Novoa, J. M., Quiros, Y., Vicente, L., Morales, A. I. & Lopez-Hernandez, F. J. New insights into the mechanism of aminoglycoside nephrotoxicity: An integrative point of view. Kidney Int. 79, 33\u201345 (2011).","journal-title":"Kidney Int."},{"key":"21074_CR8","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1681\/ASN.2014010035","volume":"25","author":"S Bell","year":"2014","unstructured":"Bell, S. et al. Risk of AKI with gentamicin as surgical prophylaxis. J. Am. Soc. Nephrol. 25, 2625\u20132632 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"21074_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","volume":"27","author":"KA Wargo","year":"2014","unstructured":"Wargo, K. A. & Edwards, J. D. Aminoglycoside-induced nephrotoxicity. J. Pharm. Pract. 27, 573\u2013577 (2014).","journal-title":"J. Pharm. Pract."},{"key":"21074_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/qjmed\/hcp143","volume":"102","author":"NM Selby","year":"2009","unstructured":"Selby, N. M., Shaw, S., Woodier, N., Fluck, R. J. & Kolhe, N. V. Gentamicin-associated acute kidney injury. QJM 102, 873\u2013880 (2009).","journal-title":"QJM"},{"key":"21074_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-100-3-352","volume":"100","author":"RD Moore","year":"1984","unstructured":"Moore, R. D., Smith, C. R., Lipsky, J. J., Mellits, E. D. & Lietman, P. S. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann. Intern. Med. 100, 352\u2013357 (1984).","journal-title":"Ann. Intern. Med."},{"key":"21074_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/infdis\/167.1.173","volume":"167","author":"JS Bertino Jr","year":"1993","unstructured":"Bertino, J. S. Jr. et al. Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J. Infect. Dis. 167, 173\u2013179 (1993).","journal-title":"J. Infect. Dis."},{"key":"21074_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.jfma.2021.02.013","volume":"120","author":"JJ Chen","year":"2021","unstructured":"Chen, J. J. et al. Risk factors and prognosis assessment for acute kidney injury: The 2020 consensus of the Taiwan AKI Task Force. J. Formos Med. Assoc. 120, 1424\u20131433 (2021).","journal-title":"J. Formos Med. Assoc."},{"key":"21074_CR14","doi-asserted-by":"publisher","first-page":"k4891","DOI":"10.1136\/bmj.k4891","volume":"364","author":"JT Poston","year":"2019","unstructured":"Poston, J. T. & Koyner, J. L. Sepsis associated acute kidney injury. BMJ 364, k4891 (2019).","journal-title":"BMJ"},{"key":"21074_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","volume":"27","author":"MC Morales-Alvarez","year":"2020","unstructured":"Morales-Alvarez, M. C. Nephrotoxicity of antimicrobials and antibiotics. Adv. Chronic Kidney Dis. 27, 31\u201337 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"21074_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int. 81, 442\u2013448 (2012).","journal-title":"Kidney Int."},{"key":"21074_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jep.2013.11.031","volume":"151","author":"YH Hsu","year":"2014","unstructured":"Hsu, Y. H. et al. Protective effects of Zhibai Dihuang Wan on renal tubular cells affected with gentamicin-induced apoptosis. J. Ethnopharmacol. 151, 635\u2013642 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"21074_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2011.02.025","volume":"658","author":"YC Chen","year":"2011","unstructured":"Chen, Y. C. et al. Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. Eur. J. Pharmacol. 658, 213\u2013218 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"21074_CR19","first-page":"694","volume":"112","author":"DC Houghton","year":"1988","unstructured":"Houghton, D. C., English, J. & Bennett, W. M. Chronic tubulointerstitial nephritis and renal insufficiency associated with long-term \u201csubtherapeutic\u201d gentamicin. J. Lab. Clin. Med. 112, 694\u2013703 (1988).","journal-title":"J. Lab. Clin. Med."},{"key":"21074_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/21655979.2021.1883887","volume":"12","author":"W Liang","year":"2021","unstructured":"Liang, W., Yu, C. J., Wang, Q. Y. & Yu, J. Anemia is associated with increased risk of contrastinduced acute kidney injury: A Systematic Review and Meta-analysis. Bioengineered 12, 648\u2013661 (2021).","journal-title":"Bioengineered"},{"key":"21074_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"JL Vincent","year":"2003","unstructured":"Vincent, J. L., Dubois, M. J., Navickis, R. J. & Wilkes, M. M. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann. Surg. 237, 319\u2013334 (2003).","journal-title":"Ann. Surg."},{"key":"21074_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla, L. S. et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat. Rev. Nephrol. 13, 241\u2013257 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"21074_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","volume":"100","author":"NH Lameire","year":"2021","unstructured":"Lameire, N. H. et al. Harmonizing acute and chronic kidney disease definition and classification: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 100, 516\u2013526 (2021).","journal-title":"Kidney Int."},{"key":"21074_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","volume":"61","author":"PM Palevsky","year":"2013","unstructured":"Palevsky, P. M. et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 61, 649\u2013672 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"21074_CR25","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/jac\/dkw296","volume":"71","author":"LZ Ong","year":"2016","unstructured":"Ong, L. Z. et al. Aminoglycoside-associated acute kidney injury in elderly patients with and without shock. J. Antimicrob. Chemother. 71, 3250\u20133257 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"21074_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","volume":"223","author":"C Martinez-Salgado","year":"2007","unstructured":"Martinez-Salgado, C., Lopez-Hernandez, F. J. & Lopez-Novoa, J. M. Glomerular nephrotoxicity of aminoglycosides. Toxicol. Appl. Pharmacol. 223, 86\u201398 (2007).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"21074_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/qjmed\/95.5.291","volume":"95","author":"D Raveh","year":"2002","unstructured":"Raveh, D. et al. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM 95, 291\u2013297 (2002).","journal-title":"QJM"},{"key":"21074_CR28","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1002\/ppul.25066","volume":"55","author":"A Saad","year":"2020","unstructured":"Saad, A. et al. Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis. Pediatr. Pulmonol. 55, 3384\u20133390 (2020).","journal-title":"Pediatr. Pulmonol."},{"key":"21074_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/SHK.0000000000001553","volume":"54","author":"R Lopez","year":"2020","unstructured":"Lopez, R. et al. Aminoglycosides in immunocompromised critically ill patients with bacterial pneumonia and septic shock: A post-hoc analysis of a prospective multicenter multinational cohort. Shock 54, 731\u2013737 (2020).","journal-title":"Shock"},{"key":"21074_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bcp.13439","volume":"84","author":"RS Hayward","year":"2018","unstructured":"Hayward, R. S. et al. Adverse effects of a single dose of gentamicin in adults: A systematic review. Br. J. Clin. Pharmacol. 84, 223\u2013238 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"21074_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/23744235.2015.1109136","volume":"48","author":"M Cobussen","year":"2016","unstructured":"Cobussen, M., de Kort, J. M., Dennert, R. M., Lowe, S. H. & Stassen, P. M. No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis. Infect. Dis. (Lond) 48, 274\u2013280 (2016).","journal-title":"Infect. Dis. (Lond)"},{"key":"21074_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/0897190014546102","volume":"27","author":"CJ Destache","year":"2014","unstructured":"Destache, C. J. Aminoglycoside-induced nephrotoxicity\u2014A focus on monitoring: a review of literature. J. Pharm. Pract. 27, 562\u2013566 (2014).","journal-title":"J. Pharm. Pract."},{"key":"21074_CR33","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00467-015-3097-3","volume":"30","author":"KJ Downes","year":"2015","unstructured":"Downes, K. J. et al. Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis. Pediatr. Nephrol. 30, 1879\u20131888 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"21074_CR34","first-page":"37","volume":"46","author":"AM Contreras","year":"1994","unstructured":"Contreras, A. M. et al. Low serum albumin and the increased risk of amikacin nephrotoxicity. Rev. Investig. Clin. 46, 37\u201343 (1994).","journal-title":"Rev. Investig. Clin."},{"key":"21074_CR35","first-page":"204","volume":"42","author":"G Gamba","year":"1990","unstructured":"Gamba, G. et al. Hypoalbuminemia as a risk factor for amikacin nephrotoxicity. Rev. Investig. Clin. 42, 204\u2013209 (1990).","journal-title":"Rev. Investig. Clin."},{"key":"21074_CR36","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1172\/JCI109784","volume":"65","author":"I Ichikawa","year":"1980","unstructured":"Ichikawa, I. et al. Mechanism of reduced glomerular filtration rate in chronic malnutrition. J. Clin. Investig. 65, 982\u2013988 (1980).","journal-title":"J. Clin. Investig."},{"key":"21074_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1538574417697211","volume":"51","author":"R Gorla","year":"2017","unstructured":"Gorla, R. et al. Impact of preoperative anemia and postoperative hemoglobin drop on the incidence of acute kidney injury and in-hospital mortality in patients with type B acute aortic syndromes undergoing thoracic endovascular aortic repair. Vasc. Endovasc. Surg. 51, 131\u2013138 (2017).","journal-title":"Vasc. Endovasc. Surg."},{"key":"21074_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12630-017-0991-0","volume":"65","author":"AD Oprea","year":"2018","unstructured":"Oprea, A. D. et al. Pre- and postoperative anemia, acute kidney injury, and mortality after coronary artery bypass grafting surgery: A retrospective observational study. Can. J. Anaesth. 65, 46\u201359 (2018).","journal-title":"Can. J. Anaesth."},{"key":"21074_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1620\/tjem.237.287","volume":"237","author":"SS Han","year":"2015","unstructured":"Han, S. S. et al. Anemia is a risk factor for acute kidney injury and long-term mortality in critically ill patients. Tohoku J. Exp. Med. 237, 287\u2013295 (2015).","journal-title":"Tohoku J. Exp. Med."},{"key":"21074_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/cells8030207","volume":"8","author":"S Shu","year":"2019","unstructured":"Shu, S. et al. Hypoxia and hypoxia-inducible factors in kidney injury and repair. Cells 8, 207 (2019).","journal-title":"Cells"},{"key":"21074_CR41","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1111\/j.1523-1755.2005.09909.x","volume":"68","author":"KU Eckardt","year":"2005","unstructured":"Eckardt, K. U. et al. Role of hypoxia in the pathogenesis of renal disease. Kidney Int. Suppl. 68, S46-51 (2005).","journal-title":"Kidney Int. Suppl."},{"key":"21074_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1365-2125.2000.00289.x","volume":"50","author":"AD McMahon","year":"2000","unstructured":"McMahon, A. D. & MacDonald, T. M. Design issues for drug epidemiology. Br. J. Clin. Pharmacol. 50, 419\u2013425 (2000).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"21074_CR43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0140-6736(94)90516-9","volume":"344","author":"J Herman","year":"1994","unstructured":"Herman, J. Experiment and observation. Lancet 344, 1209\u20131211 (1994).","journal-title":"Lancet"},{"key":"21074_CR44","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0021-9681(86)90207-9","volume":"39","author":"JP Vandenbroucke","year":"1986","unstructured":"Vandenbroucke, J. P. Is the randomized controlled trial the real paradigm in epidemiology?. J. Chronic Dis. 39, 572\u2013574 (1986).","journal-title":"J. Chronic Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21074-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21074-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21074-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T10:14:33Z","timestamp":1665742473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21074-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21074"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21074-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17212"}}